Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision ...
Nina S. Kjellson, a director at Tyra Biosciences , Inc. (NASDAQ:TYRA), recently sold shares of the company's common stock totaling $74,323. The timing of this insider sale comes as the stock trades ...
This receptor tyrosine kinase plays a vital role in controlling cellular growth and differentiation, and activating FGFR3 mutations or fusions are frequently observed in NMIBC, especially in papillary ...
Tasurgratinib (also known as E-7090) is an oral selective FGFR1, FGFR2, and FGFR3 inhibitor that, if approved, will join other drugs in the class on the market, including Incyte’s Pemazyre ...
It’s Your Money, Your Future—Own It (sponsor) Retirement can be daunting, but it doesn’t need to be. Imagine having an expert in your corner to help you with your financial goals. Someone to ...
Don't want to spend a fortune and break the bank on investing in growth stocks? The ones listed here all cost less than $100. Even if you can't make a big lump sum investment, you can add steadily ...
Genetics is the branch of science concerned with genes, heredity, and variation in living organisms. It seeks to understand the process of trait inheritance from parents to offspring, including ...
A year earlier ImmunoGen revealed that the alliance had yielded three candidates, including one ADC directed at fibroblast growth factor receptor 3 (FGFR3) associated with bladder and brain ...
The government’s economic stimulus measures would help boost Thai economic growth by 3.5% this year, Deputy Finance Minister Julapun Amornvivat made his speech in the seminar “Economic Drives 2025” by ...
Our goal here is to highlight some of our past recommendations that we think are of particular interest today, due to a combination of business performance and potentially attractive share valuation.
Borosil Limited reported a mixed performance in the third quarter of FY25, with revenue growing in double digits, but profitability taking a hit. The company’s net profit declined 6.4% year-on-year to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results